C4 Therapeutics, Inc.·4

Apr 6, 4:30 PM ET

COHEN ALAIN J 4

4 · C4 Therapeutics, Inc. · Filed Apr 6, 2021

Insider Transaction Report

Form 4
Period: 2021-04-05
COHEN ALAIN J
Director10% Owner
Transactions
  • Award

    Common Stock

    2021-04-05$37.51/sh+266$9,978266 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,719,332
  • Common Stock

    (indirect: By Cobro Ventures Opportunity Fund, L.P.)
    2,484,425
Footnotes (4)
  • [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021.
  • [F3]Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F4]Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION